Catherine Schulte
Stock Analyst at Baird
(4.05)
# 349
Out of 4,829 analysts
126
Total ratings
53.27%
Success rate
9.91%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXAS Exact Sciences | Maintains: Outperform | $69 → $72 | $53.40 | +34.83% | 14 | May 2, 2025 | |
| AVTR Avantor | Maintains: Outperform | $21 → $17 | $13.00 | +30.77% | 11 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $603 → $573 | $432.59 | +32.46% | 26 | Apr 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $231 → $225 | $200.83 | +12.04% | 8 | Apr 23, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,369 → $1,034 | $1,174.59 | -11.97% | 8 | Apr 22, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $42.96 | +0.09% | 4 | Apr 21, 2025 | |
| A Agilent Technologies | Maintains: Outperform | $161 → $159 | $115.55 | +37.60% | 15 | Feb 27, 2025 | |
| MRVI Maravai LifeSciences Holdings | Downgrades: Neutral | $9 → $3 | $2.12 | +41.51% | 5 | Feb 26, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $53.90 | +26.16% | 10 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $17.04 | +123.00% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $32.95 | +0.15% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $81.57 | +244.49% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $366.67 | -40.82% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $157.29 | -87.28% | 1 | Jun 28, 2018 |
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $69 → $72
Current: $53.40
Upside: +34.83%
Avantor
Apr 28, 2025
Maintains: Outperform
Price Target: $21 → $17
Current: $13.00
Upside: +30.77%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $603 → $573
Current: $432.59
Upside: +32.46%
Danaher
Apr 23, 2025
Maintains: Outperform
Price Target: $231 → $225
Current: $200.83
Upside: +12.04%
Mettler-Toledo International
Apr 22, 2025
Maintains: Neutral
Price Target: $1,369 → $1,034
Current: $1,174.59
Upside: -11.97%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $42.96
Upside: +0.09%
Agilent Technologies
Feb 27, 2025
Maintains: Outperform
Price Target: $161 → $159
Current: $115.55
Upside: +37.60%
Maravai LifeSciences Holdings
Feb 26, 2025
Downgrades: Neutral
Price Target: $9 → $3
Current: $2.12
Upside: +41.51%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $53.90
Upside: +26.16%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $17.04
Upside: +123.00%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $32.95
Upside: +0.15%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $81.57
Upside: +244.49%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $366.67
Upside: -40.82%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $157.29
Upside: -87.28%